Grizzly Discoveries (CVE:GZD) Hits New 12-Month Low at $0.03

Share on StockTwits

Grizzly Discoveries Inc (CVE:GZD)’s share price reached a new 52-week low on Tuesday . The company traded as low as C$0.03 and last traded at C$0.03, with a volume of 7000 shares traded. The stock had previously closed at C$0.04.

The stock has a market cap of $2.01 million and a price-to-earnings ratio of -1.03. The stock’s 50-day simple moving average is C$0.04 and its two-hundred day simple moving average is C$0.05.

About Grizzly Discoveries (CVE:GZD)

Grizzly Discoveries Inc engages in the acquisition, exploration, and development of mineral properties in Canada. It primarily explores for gold, copper, cobalt, potash, and diamond deposits. As of November 1, 2018, it had interests in approximately 189,000 acres of precious-base metal properties in British Columbia along with metallic and industrial mineral permits for potash totaling approximately 60,000 acres along the Alberta-Saskatchewan border; and approximately 161,000 acres of properties, which host diamondiferous kimberlites in the Buffalo Head Hills region of Alberta.

Recommended Story: 52-week highs

Receive News & Ratings for Grizzly Discoveries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grizzly Discoveries and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Bitcoin Private   Trading 4.7% Lower  This Week
Bitcoin Private Trading 4.7% Lower This Week
Joint Ventures  Trading 3.1% Higher  Over Last Week
Joint Ventures Trading 3.1% Higher Over Last Week
Bitradio 24-Hour Trading Volume Reaches $50.00
Bitradio 24-Hour Trading Volume Reaches $50.00
Aegeus Reaches Market Capitalization of $26,594.00
Aegeus Reaches Market Capitalization of $26,594.00
Extraction Oil & Gas Inc  Expected to Announce Earnings of -$0.07 Per Share
Extraction Oil & Gas Inc Expected to Announce Earnings of -$0.07 Per Share
$6.90 Million in Sales Expected for Cytosorbents Corp  This Quarter
$6.90 Million in Sales Expected for Cytosorbents Corp This Quarter


© 2006-2019 Ticker Report